CTSN PACES (A-Fib) - Clinical Trial

What is the Purpose of this Study?

We are doing this research to learn more about whether taking a blood thinner, along with medications that prevent blood clots, improve outcomes in patients who develop atrial fibrillation (irregular heartbeat) after coronary artery bypass grafting surgery.

What is the Condition Being Studied?

Atrial Fibrillation (A-Fib)

Who Can Participate in the Study?

Adults who developed atrial fibrillation after coronary artery bypass grafting surgery.

Age Group
Adults

What is Involved?

If you agree to be in this study, you will:
- Be randomly assigned (a fair 50/50 chance) to get the study drug or aspirin for 90 days
- Have an in-person study visit at 90 days
- Have blood tests
- Fill out questionnaires
- Have an ECGs (looks at your heart)
- Have phone up to 4 phone calls with a member of the study team

If you do not want to be part of the randomized study you may participate in a registry collecting data from your hospitalization for atrial fibrillation.

Study Details

Full Title
Anticoagulation for the New-Onset Post-Operative Atrial Fibrillation after CABG
Principal Investigator
Protocol Number
IRB: PRO00103761
NCT: NCT04045665
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698